These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30332439)

  • 1. Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition.
    Benito-Vicente A; Uribe KB; Siddiqi H; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Cenarro A; Stef M; Ostolaza H; Civeira F; Palacios L; Martin C
    PLoS One; 2018; 13(10):e0204771. PubMed ID: 30332439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats.
    Etxebarria A; Benito-Vicente A; Stef M; Ostolaza H; Palacios L; Martin C
    Atherosclerosis; 2015 Feb; 238(2):304-12. PubMed ID: 25545329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro.
    Benito-Vicente A; Siddiqi H; Uribe KB; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Stef M; Ostolaza H; Palacios L; Martin C
    Sci Rep; 2018 Nov; 8(1):16614. PubMed ID: 30413722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The important role for betaVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor.
    Iwasaki T; Takahashi S; Ishihara M; Takahashi M; Ikeda U; Shimada K; Fujino T; Yamamoto TT; Hattori H; Emi M
    J Hum Genet; 2004; 49(11):622-628. PubMed ID: 15459764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of six uncharacterised mutations in LDLR gene.
    Gomez A; Colombo R; Pontoglio A; Helman L; Kaeser L; Giunta G; Parolin ML; Toscanini U; Cuniberti L
    Atherosclerosis; 2019 Dec; 291():44-51. PubMed ID: 31689621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
    Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
    Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR.
    Galicia-Garcia U; Benito-Vicente A; Uribe KB; Jebari S; Larrea-Sebal A; Alonso-Estrada R; Aguilo-Arce J; Ostolaza H; Palacios L; Martin C
    Sci Rep; 2020 Feb; 10(1):1727. PubMed ID: 32015373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia.
    Graadt van Roggen JF; van der Westhuyzen DR; Coetzee GA; Marais AD; Steyn K; Langenhoven E; Kotze MJ
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):765-72. PubMed ID: 7773731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of splicing and ligand-binding domain variants in the LDL receptor.
    Etxebarria A; Palacios L; Stef M; Tejedor D; Uribe KB; Oleaga A; Irigoyen L; Torres B; Ostolaza H; Martin C
    Hum Mutat; 2012 Jan; 33(1):232-43. PubMed ID: 21990180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.
    Jones C; Garuti R; Michaely P; Li WP; Maeda N; Cohen JC; Herz J; Hobbs HH
    J Clin Invest; 2007 Jan; 117(1):165-74. PubMed ID: 17200716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene.
    Jiang L; Benito-Vicente A; Tang L; Etxebarria A; Cui W; Uribe KB; Pan XD; Ostolaza H; Yang SW; Zhou YJ; Martin C; Wang LY
    Atherosclerosis; 2017 Aug; 263():163-170. PubMed ID: 28645073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia.
    Rodríguez-Jiménez C; Pernía O; Mostaza J; Rodríguez-Antolín C; de Dios García-Díaz J; Alonso-Cerezo C; García-Polo I; Blanco A; Lahoz C; Arrieta F; Beltrán L; Díaz de Bustamante A; Garzón-Lorenzo L; Álvarez-Sala LA; Asenjo Á; Ibáñez de Cáceres I; Rodríguez-Nóvoa S
    Hum Mutat; 2019 Aug; 40(8):1181-1190. PubMed ID: 31106925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
    Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
    J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization and classification of frequent low-density lipoprotein receptor variants.
    Etxebarria A; Benito-Vicente A; Palacios L; Stef M; Cenarro A; Civeira F; Ostolaza H; Martin C
    Hum Mutat; 2015 Jan; 36(1):129-41. PubMed ID: 25378237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.
    Banerjee P; Chan KC; Tarabocchia M; Benito-Vicente A; Alves AC; Uribe KB; Bourbon M; Skiba PJ; Pordy R; Gipe DA; Gaudet D; Martin C
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2248-2260. PubMed ID: 31578082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of Familial hypercholesterolemia patients.
    Barbosa TKA; Hirata RDC; Ferreira GM; Borges JB; Oliveira VF; Gorjão R; Marçal ERDS; Gonçalves RM; Faludi AA; Freitas RCC; Dagli-Hernandez C; Bortolin RH; Bastos GM; Pithon-Curi TC; Nader HB; Hirata MH
    Gene; 2023 Feb; 853():147084. PubMed ID: 36464169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.